Skip to main content

Microbots Deliver Stem Cells in the Body

The astonishing thing about stem cells is that they can be coaxed, in the laboratory, into becoming nearly any kind of cell—from bone marrow to heart muscle. That remarkable capability has for years kept scientists busy tinkering with stem cells and injecting them into animal models in an attempt to grow and replace damaged tissue.  

Such scientists have received a ton of attention in that line of work. But there’s a smaller group of researchers working, to far less fanfare, on a different part of the stem cell challenge: how to deliver those cells to the body’s hard-to-reach places.

Researchers typically deliver stem cells via injection—a needle. But that method can damage healthy tissue, especially when the target is a deep brain structure, or delicate vasculature, or the inner ear.


A group out of Hong Kong announced this week that they had invented a new delivery tool using tiny, magnetically-controlled robots. The cell-carrying machines move noninvasively through the body to a target site and deliver their stem cell cargo.

The researchers, led by Dong Sun, a professor at City University of Hong Kong, demonstrated their device in zebrafish and mice, and reported their success in the journal Science Robotics.

The advance is notable because Sun and his colleagues were able to demonstrate that their robots work in animals. “It’s really uncertain how to make these tiny machines move in living organisms,” says Bradley Nelson, a microroboticist at ETH Zürich, who was not involved in the project. 

Several other groups, including Nelson’s, have demonstrated cell-carrying microbot designs in computer simulations and test tubes, but “in vivo is harder,” he says. 

Sun designed the robots to resemble burrs (the prickly spherical seed pods that cling to clothing). He and his colleagues fabricated them using 3D laser lithography, and coated them in nickel for magnetic actuation, and titanium, for biocompatibility.

The porous, burr-shaped bots hold cells between their spikes. Using magnetic fields, researchers can guide the bots to a site of interest in the body. There, they release the cells, which then proliferate and do their job in regenerating damaged tissue.

Sun and his colleagues tested the mobility of the robots by injecting them into the yolks of anesthetized zebrafish embryos. They navigated them around to specified points inside the yolk while observing that the heart of the zebrafish continued to beat. 

Then they tested whether the robots could carry and release cells. They loaded them up with a voracious type of cell called HeLa, and injected swarms of them into mice. The robots did their job in releasing the cells, which then proliferated in the mice.

A next step would be to load up the microbots with stem cells to test their therapeutic capabilities. One limitation of the design is that the cells are released spontaneously, rather than with a controlled mechanism.

Nelson cautions that Sun’s burr-bots are only one piece in the stem cell puzzle. Far more work must be done before stem cell therapies can be used to actually heal organs or treat disease. 

The cell-carrying bots add to the growing list of medical microrobots designed to perform various jobs in the body, such as delivering drugs or fighting infections.

Source : https://goo.gl/NyCfcT

Comments

  1. Great post, thanks for sharing, That’s a awesome article you posted and very useful for me. Check out more about stem cell therapy clinics.

    ReplyDelete

Post a Comment

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...